Go Pro
→ Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid (From Altimetry) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DexCom, Inc. stock logo
DXCM
DexCom
$89.88
+0.3%		$76.85
$54.11
▼
$91.96
$33.81B1.415.40 million shs8.67 million shs
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$1,280.62
+4.5%		$1,176.04
$685.15
▼
$1,292.65
$1.15T0.512.64 million shs4.54 million shs
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$46.40
+1.5%		$47.58
$35.12
▼
$64.16
$204.10B0.7613.59 million shs19.48 million shs
Ollie's Bargain Outlet Holdings, Inc. stock logo
OLLI
Ollie's Bargain Outlet
$79.39
+4.2%		$73.11
$60.29
▼
$140.17
$4.61B0.461.34 million shs1.47 million shs
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
$6.65
+2.7%		$8.12
$4.40
▼
$9.89
$1.18B2.126.07 million shs3.22 million shs
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DexCom, Inc. stock logo
DXCM
DexCom
+0.95%+0.08%+16.89%+25.42%+10.86%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
+3.60%+1.17%+4.17%+20.77%+75.58%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
+1.83%-3.19%-9.11%+1.43%-15.05%
Ollie's Bargain Outlet Holdings, Inc. stock logo
OLLI
Ollie's Bargain Outlet
+1.71%-3.18%+14.58%-7.34%-43.05%
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-1.42%-5.25%-31.59%-0.28%-13.81%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DexCom, Inc. stock logo
DXCM
DexCom
$89.88
+0.3%		$76.85
$54.11
▼
$91.96
$33.81B1.415.40 million shs8.67 million shs
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$1,280.62
+4.5%		$1,176.04
$685.15
▼
$1,292.65
$1.15T0.512.64 million shs4.54 million shs
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$46.40
+1.5%		$47.58
$35.12
▼
$64.16
$204.10B0.7613.59 million shs19.48 million shs
Ollie's Bargain Outlet Holdings, Inc. stock logo
OLLI
Ollie's Bargain Outlet
$79.39
+4.2%		$73.11
$60.29
▼
$140.17
$4.61B0.461.34 million shs1.47 million shs
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
$6.65
+2.7%		$8.12
$4.40
▼
$9.89
$1.18B2.126.07 million shs3.22 million shs
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DexCom, Inc. stock logo
DXCM
DexCom
+0.95%+0.08%+16.89%+25.42%+10.86%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
+3.60%+1.17%+4.17%+20.77%+75.58%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
+1.83%-3.19%-9.11%+1.43%-15.05%
Ollie's Bargain Outlet Holdings, Inc. stock logo
OLLI
Ollie's Bargain Outlet
+1.71%-3.18%+14.58%-7.34%-43.05%
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-1.42%-5.25%-31.59%-0.28%-13.81%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
DexCom, Inc. stock logo
DXCM
DexCom
2.89
Moderate Buy$88.71-1.30% Downside
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
2.83
Moderate Buy$1,292.180.90% Upside
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
2.20
Hold$64.9439.96% Upside
Ollie's Bargain Outlet Holdings, Inc. stock logo
OLLI
Ollie's Bargain Outlet
2.76
Moderate Buy$110.2038.81% Upside
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
2.25
Hold$7.5413.40% Upside

Current Analyst Ratings Breakdown

Latest TDOC, OLLI, DXCM, LLY, and NVO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/18/2026
Ollie's Bargain Outlet Holdings, Inc. stock logo
OLLI
Ollie's Bargain Outlet
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOverweight$114.00 ➝ $113.00
8/18/2026
Ollie's Bargain Outlet Holdings, Inc. stock logo
OLLI
Ollie's Bargain Outlet
JPMorgan Chase & Co. logo
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$70.00 ➝ $73.00
8/17/2026
Ollie's Bargain Outlet Holdings, Inc. stock logo
OLLI
Ollie's Bargain Outlet
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOverweight$115.00 ➝ $100.00
8/12/2026
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Berenberg Bank logo
Berenberg Bank
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$47.00
8/12/2026
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Berenberg Bank logo
Berenberg Bank
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy ➝ Hold
8/11/2026
DexCom, Inc. stock logo
DXCM
DexCom
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C-) ➝ Hold (C)
8/11/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy (B) ➝ Buy (B-)
8/11/2026
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong Sell ➝ Hold
8/7/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$1,376.00
8/7/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$1,370.00 ➝ $1,376.00
8/6/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Morgan Stanley logo
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight$1,419.00
(Data available from 8/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
DexCom, Inc. stock logo
DXCM
DexCom
$4.66B7.28$2.78 per share32.36$6.95 per share12.93
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$65.18B18.50$26.26 per share48.76$35.99 per share35.58
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$46.80B4.43$4.76 per share9.75$6.58 per share7.05
Ollie's Bargain Outlet Holdings, Inc. stock logo
OLLI
Ollie's Bargain Outlet
$2.65B1.81$4.99 per share15.91$30.78 per share2.58
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
$2.53B0.48$1.85 per share3.59$7.21 per share0.92
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
DexCom, Inc. stock logo
DXCM
DexCom
$836.30M$2.5335.5329.181.5120.12%35.94%14.75%10/29/2026 (Estimated)
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$20.64B$29.8042.9727.921.4533.53%97.83%23.23%10/29/2026 (Estimated)
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$15.51B$4.0911.3413.774.1435.36%61.20%21.49%11/4/2026 (Estimated)
Ollie's Bargain Outlet Holdings, Inc. stock logo
OLLI
Ollie's Bargain Outlet
$240.60M$4.0519.6015.811.359.13%13.43%8.56%8/27/2026 (Estimated)
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-$200.32M-$0.99N/AN/AN/A-7.13%-12.15%-5.83%10/28/2026 (Estimated)

Latest TDOC, OLLI, DXCM, LLY, and NVO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/27/2026Q2 2026
Ollie's Bargain Outlet Holdings, Inc. stock logo
OLLI
Ollie's Bargain Outlet
$1.13N/AN/AN/A$753.75 millionN/A
8/5/2026Q2 2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$6.40$8.38+$1.98$7.94$20.82 billion$22.97 billion
8/5/2026Q2 2026
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$0.77$0.96+$0.19$0.72$10.89 billion$11.98 billion
7/30/2026Q2 2026
DexCom, Inc. stock logo
DXCM
DexCom
$0.6110$0.70+$0.0890$0.64$1.29 billion$1.31 billion
7/29/2026Q2 2026
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-$0.2498-$0.21+$0.0398-$0.21$615.44 million$606.93 million
6/30/2026Q2 2026
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
N/A$0.9440N/A$0.72N/A$11.98 billion
6/3/2026Q1 2026
Ollie's Bargain Outlet Holdings, Inc. stock logo
OLLI
Ollie's Bargain Outlet
$0.87$0.91+$0.04$0.92$661.65 million$658.93 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
DexCom, Inc. stock logo
DXCM
DexCom
N/AN/AN/AN/AN/A
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$6.920.54%+15.18%23.22%11 Years
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$0.811.75%+21.74%19.80%N/A
Ollie's Bargain Outlet Holdings, Inc. stock logo
OLLI
Ollie's Bargain Outlet
N/AN/AN/AN/AN/A
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
N/AN/AN/AN/AN/A

Latest TDOC, OLLI, DXCM, LLY, and NVO Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/22/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
quarterly$1.730.59%8/14/20268/14/20269/10/2026
8/5/2026
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$0.57862.58%8/17/20268/17/20268/25/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
DexCom, Inc. stock logo
DXCM
DexCom
0.47
1.73
1.43
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
1.41
1.35
1.00
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
0.59
0.79
0.56
Ollie's Bargain Outlet Holdings, Inc. stock logo
OLLI
Ollie's Bargain Outlet
N/A
2.32
0.66
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
N/A
0.83
0.81

Institutional Ownership

CompanyInstitutional Ownership
DexCom, Inc. stock logo
DXCM
DexCom
97.75%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
82.53%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
11.54%
Ollie's Bargain Outlet Holdings, Inc. stock logo
OLLI
Ollie's Bargain Outlet
N/A
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
76.82%

Insider Ownership

CompanyInsider Ownership
DexCom, Inc. stock logo
DXCM
DexCom
0.28%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
0.14%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
0.07%
Ollie's Bargain Outlet Holdings, Inc. stock logo
OLLI
Ollie's Bargain Outlet
0.75%
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
0.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
DexCom, Inc. stock logo
DXCM
DexCom
11,000377.36 million376.30 millionOptionable
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
50,000941.36 million940.04 millionOptionable
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
69,5054.47 billion4.46 billionOptionable
Ollie's Bargain Outlet Holdings, Inc. stock logo
OLLI
Ollie's Bargain Outlet
13,00060.45 million60.00 millionOptionable
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
5,600181.68 million180.41 millionOptionable

Recent News About These Companies

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Teladoc Health, Inc. – TDOC
August 18 at 5:54 PM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/18/3347331/1087/en/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-teladoc-health-inc-tdoc.html
U.S. Mental Health Treatment Market Report 2026–2030: Evaluating $159 Billion Forecast, Digital App Adoption, and Strategies of Acadia Healthcare, UHS, Talkspace, and Elevance Health
August 17 at 8:34 AM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/u-mental-health-treatment-market-095500402.html
Monaco Asset Management SAM Takes $26.86 Million Position in Teladoc Health, Inc. $TDOC
August 17 at 6:32 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-monaco-asset-management-sam-takes-2686-million-position-in-teladoc-health-inc-tdoc-2026-08-17/
Did Teladoc Health, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
August 17 at 2:43 AM  |  prnewswire.comhttps://www.prnewswire.com/news-releases/did-teladoc-health-inc-insiders-breach-their-fiduciary-duties-to-shareholders-302852534.html
Teladoc Announces Upcoming Retirement of Longtime Board Director
August 13, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/teladoc-announces-upcoming-retirement-of-longtime-board-director?utm_source=marketbeat.com&utm_medium=referral
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC
August 13, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-teladoc-health-inc---tdoc-302850536.html
HNGE Rallies 64.6% in 3 Months as Growth and Margins Gain Momentum
August 12, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/hnge-rallies-64-6-3-165300965.html
Hinge Health's Cylinder Deal Opens a $135B GI Care Growth Opportunity
August 12, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/hinge-healths-cylinder-deal-opens-165700433.html
Is Hinge Health Stock a Buy as Growth Accelerates and Risks Rise?
August 12, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/hinge-health-stock-buy-growth-170300150.html
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC
August 11, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/11/3343296/1087/en/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-teladoc-health-inc-tdoc.html
1 Internet Stock with Impressive Fundamentals and 2 We Question
August 9, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/1-internet-stock-impressive-fundamentals-222122758.html
Teladoc Health (TDOC) Q2 2026 Earnings Call Transcript
August 8, 2026  |  fool.comhttps://www.fool.com/earnings/call-transcripts/2026/08/07/teladoc-health-tdoc-q2-2026-earnings-call-transcript/
Teladoc Health (TDOC) Securities Investigation Notice - Levi & Korsinsky
August 7, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/teladoc-health-tdoc-securities-investigation-notice---levi--korsinsky-302845696.html
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC
August 6, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-teladoc-health-inc---tdoc-302845600.html
Securities Fraud Investigation Into Teladoc Health Inc. (TDOC) Announced - Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
August 6, 2026  |  tmcnet.comhttps://www.tmcnet.com/usubmit/2026/08/05/10426182.htm
Analysts Have Conflicting Sentiments on These Healthcare Companies: Teladoc (TDOC) and Karyopharm Therapeutics (KPTI)
August 6, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/TDOC/pressreleases/3651867/analysts-have-conflicting-sentiments-on-these-healthcare-companies-teladoc-tdoc-and-karyopharm-therapeutics-kpti/
Securities Fraud Investigation Into Teladoc Health Inc. (TDOC) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
August 5, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260805805868/en/securities-fraud-investigation-into-teladoc-health-inc.-tdoc-announced-%e2%80%93-shareholders-who-lost-money-urged-to-contact-the-law-offices-of-frank-r.-cruz/
Teladoc Shares Plunged More Than 28% After Earnings. How to Play TDOC Here.
August 5, 2026  |  barchart.comhttps://www.barchart.com/story/news/3665288/teladoc-shares-plunged-more-than-28-after-earnings-how-to-play-tdoc-here
Teladoc shares plunged more than 28% after earnings. How to play TDOC here.
August 5, 2026  |  msn.comhttps://www.msn.com/en-us/money/topstocks/teladoc-shares-plunged-more-than-28-after-earnings-how-to-play-tdoc-here/ar-AA29soe7
Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Teladoc Health (TDOC)
August 5, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/05/3339447/3080/en/levi-korsinsky-notifies-investors-of-pending-investigation-into-securities-claims-involving-teladoc-health-tdoc.html
TDOC Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Teladoc Health (TDOC)
August 5, 2026  |  tmcnet.comhttps://www.tmcnet.com/usubmit/2026/08/04/10425111.htm

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Laboratory with a cryogenic quantum processor chamber, optical laser setup on a table, and data monitors displaying waveforms.
Quantum Earnings Week: Winners and Losers Are Finally Emerging
By Nathan Reiff | August 8, 2026
Laptop displaying stock price and bar charts on a desk, surrounded by icons representing tech, banking, healthcare, and retail sectors.
The S&P 493 Are Staging a Comeback—This Value ETF Offers Broad Exposure
By Jessica Mitacek | August 3, 2026
NVIDIA logo displayed on a computer chip surrounded by illuminated green circuit board traces.
NVIDIA’s Rally Sets Up a Bigger Test Ahead of Earnings
By Thomas Hughes | August 11, 2026
ADM company logo sign displayed in a crop field with grain storage silos and processing facility in the background.
Is ADM’s Rally Getting Ahead of Its Policy Tailwind?
By Chris Markoch | August 5, 2026
An upward-trending arrow drawn in beach sand, symbolizing rising stock prices, with beachgoers in the background.
3 Stocks Taking Very Different Routes Through the Summer Rally
By Nathan Reiff | August 5, 2026
DexCom stock logo

DexCom NASDAQ:DXCM

$89.88 +0.28 (+0.31%)
Closing price 04:00 PM Eastern
Extended Trading
$89.41 -0.47 (-0.52%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

Eli Lilly and Company stock logo

Eli Lilly and Company NYSE:LLY

$1,280.62 +54.89 (+4.48%)
Closing price 03:59 PM Eastern
Extended Trading
$1,279.12 -1.50 (-0.12%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Novo Nordisk A/S stock logo

Novo Nordisk A/S NYSE:NVO

$46.40 +0.69 (+1.51%)
Closing price 03:59 PM Eastern
Extended Trading
$46.87 +0.47 (+1.02%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products; and with Korro Bio, Inc. for the discovery and development of new genetic medicines to treat cardiometabolic diseases. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Ollie's Bargain Outlet stock logo

Ollie's Bargain Outlet NASDAQ:OLLI

$79.39 +3.18 (+4.17%)
Closing price 04:00 PM Eastern
Extended Trading
$79.38 -0.02 (-0.02%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Ollie's Bargain Outlet Holdings, Inc. is a holding company, which engages in the retail of closeouts, excess inventory, and salvage merchandise. It offers overstocks, package changes, manufacturer refurbished goods, and irregulars. The company's products include housewares, food, books and stationery, bed and bath, floor coverings, electronics and toys. Ollie's Bargain Outlet Holdings was founded by Mark Butler, Mort Bernstein, Oliver Rosenberg and Harry Coverman on July 29, 1982, and is headquartered in Harrisburg, PA.

Teladoc Health stock logo

Teladoc Health NYSE:TDOC

$6.64 +0.18 (+2.70%)
Closing price 03:59 PM Eastern
Extended Trading
$6.63 -0.01 (-0.23%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas